InvestorsHub Logo
Followers 536
Posts 34552
Boards Moderated 7
Alias Born 02/28/2013

Re: None

Wednesday, 10/25/2023 8:57:42 AM

Wednesday, October 25, 2023 8:57:42 AM

Post# of 546
"Excellos is excited to partner with TCBP to enable novel cell therapies for a number of cancer indications," said David Wellis, Ph.D., CEO of Excellos. "We share the vision of starting with deeply characterized cells to create cGMP compliant cell banks, which ultimately may enhance clinical trial success and optimized final product. Excellos believes this type of partnership is commercially significant for therapeutic companies looking for end-to-end support from collection and analysis of starting material through commercial product, and it supports our recent launch of our validated commercial cell manufacturing facility in San Diego, California."

“Be Fearful When Others Are Greedy and Greedy When Others Are Fearful”


Warren Buffett

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TCBP News